People walk by a CVS Pharmacy store in the Manhattan borough of New York City.

Shannon Stapleton | Reuters

CVS Health on Wednesday lifted its earnings outlook for the year, after beating Wall Street’s expectations for the fiscal second quarter.

The health-care company said it now expects adjusted earnings per share for the full year to come in between $8.40 and $8.60, compared with its earlier estimate of between $8.20 and $8.40.

Shares rose about 2% in premarket trading.

Here’s what the company reported for the three-month period ended June 30, compared with what analysts were expecting, based on a survey of analysts by Refinitiv:

  • Earnings per share: $2.40 adjusted vs. $2.17 expected
  • Revenue: $80.64 billion vs. $76.37 billion expected

On an unadjusted basis, CVS reported net income of $2.95 billion, or $2.23 per share, higher than the $2.78 billion, or $2.10 per share, a year earlier. Revenue of $80.64 billion likewise marked a year-over-year increase, up from $72.62 billion in the same period in 2021.

Shares of CVS closed on Tuesday at $95.37. The company’s shares have fallen about 8% so far this year.

This is a developing story. Please check back for updates.

Post source: cnbc

You May Also Like

Nationwide’s rush to buy Virgin Money risks member backlash, says ALEX BRUMMER

Nationwide’s aggressive pursuit of Virgin Money has sparked concerns among its members,…

5 Reasons Why Tenant Screening is Important

Tenant screening is crucial in helping property managers and landlords learn more…

Pfizer Reduces Stake in Haleon From 32% Down To 24%

Report Pfizer Reduces Stake in Haleon From 32% Down To 24% –…

Mike Lynch Accused of Fraud in Autonomy Sale to HP

Mike Lynch, the founder of Autonomy, a software company that was sold…